当前位置: 首页 > 详情页

Correlation between B7-H3 expression and rheumatoid arthritis: A new polymorphism haplotype is associated with increased disease risk

文献详情

资源类型:

收录情况: ◇ SCIE

机构: [a]Institute of Medical Biotechnology, Suzhou Health College, Suzhou, Jiangsu 215009, PR China [b]Jiangsu Institute of Clinical Immunology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215007, PR China [c]Wuxi Red Cross Blood Center, Wuxi, PR China [d]Department of Special Requirements Ward, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, PR China [e]Department of Clinical Laboratory, The Second Affiliated Hospital of Soochow University, PR China
出处:
ISSN:

关键词: Rheumatoid arthritis (RA) B7-H3/CD276 Single nucleotide polymorphisms (SNPs) Gene expression

摘要:
CD276 (B7-H3) is a costimulatory molecule that plays a potent role in T cell responses, however, the role of B7-H3 in autoimmune diseases has not been elucidated. We analyzed B7-H3 expression in rheumatoid arthritis (RA) for the first time and found B7-H3 was significantly up-regulated on monocytes in RA patients, while the levels of soluble B7-H3 in serum were lower than in controls (P < 0.0001). These differences correlated with clinical and laboratory disease parameters and informatory factor TNF-alpha. Through in vitro experiments, we demonstrated that B7-H3 promoted TNF-alpha secretion. In addition, a new polymorphism variant, B7-H3-T-A-C-T, was identified and shown to be associated with the incidence of RA and the decreased release of sB7-H3. These results suggest that B7-H3 may be a promising biomarker associated with the pathogenesis of RA. Notably, the new B7-H3-T-A-C-T polymorphism variant is associated with RA risk and might be associated with the release of soluble B7-H3. (C) 2015 Elsevier Inc. All rights reserved.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2014]版:
大类 | 2 区 医学
小类 | 3 区 免疫学
最新[2023]版:
大类 | 3 区 医学
小类 | 3 区 免疫学
JCR分区:
出版当年[2013]版:
Q2 IMMUNOLOGY
最新[2023]版:
Q2 IMMUNOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2013版] 出版当年五年平均 出版前一年[2012版] 出版后一年[2014版]

第一作者:
第一作者机构: [a]Institute of Medical Biotechnology, Suzhou Health College, Suzhou, Jiangsu 215009, PR China
共同第一作者:
通讯作者:
通讯机构: [a]Institute of Medical Biotechnology, Suzhou Health College, Suzhou, Jiangsu 215009, PR China [b]Jiangsu Institute of Clinical Immunology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215007, PR China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16409 今日访问量:0 总访问量:869 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院